NIAID HIV and Emerging Infectious Diseases Program

Healthy Volunteer Studies

Studies of healthy volunteers are crucial to the understanding and treatment of diseases. They provide a baseline for measuring the extent of disease and provide important information about the safety and effectiveness of various treatments.

There is no risk of contracting HIV/AIDS from any of these studies.

For questions about participating in any of these clinical studies, contact: Patient Recruitment and Public Liaison Office Toll Free: 1-800-411-1222 TTY: 1-866-411-1010 Se habla español. Office hours: 8 am to 8 pm, Eastern Time

Correlation of the Precursor Frequency of CD4 + Effector Memory T Cells with Induration Measured in the Tuberculin Skin Test

(TST - Protocol #06-I-0030)

NIH is conducting a research study to investigate the human immune response to tuberculosis infection. Volunteers over 18 years old who have not been treated for tuberculosis are eligible to participate. The study involves up to 6 visits for placement of a tuberculin skin test and follow-up blood tests. The study is recruiting patients residing in the Washington, DC, Maryland, and Virginia metropolitan area. Volunteers will be compensated.

Drug Interaction Study Between Orally Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers

(BECPK - Protocol #09-CC-0186)

We are seeking HIV-negative male and female volunteers ages 18 – 50 years for a research study to determine drug interactions among an inhaled steroid, beclomethasone (Qvar®), and two protease inhibitors used to treat HIV, darunavir (Prezista®) and ritonavir (Norvir®). In order to participate, you must be in good health, and take no prescription or over-the-counter medications routinely. Volunteers will be compensated.

back to top